High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
European Journal of Neurology · 2023
DOI: 10.1111/ene.15742 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Arabella Buchmann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Multiple Sclerosis, Central Nervous System Diseases, Neurodegenerative Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose Serum neurofilament light chain (sNfL) is a promising biomarker of neuroaxonal damage in persons with multiple sclerosis (pwMS). In cross‐sectional studies, sNfL has been associated with disease activity and brain magnetic resonance imaging (MRI) changes; however, it is still unclear to what extent in particular high sNfL levels impact on subsequent disease evolution. Methods sNfL was quantified by an ultrasensitive single molecule array (Simoa) in 199 pwMS (median age = 34.2 years, 64.3% female) and 49 controls. All pwMS underwent 3‐T MRI to assess global and compartmental normalized brain volumes, T2‐lesion load, and cortical mean thickness. Follow‐up data and serum samples were available in 144 pwMS (median follow‐up time = 3.8 years). Linear and binary logistic models were used to estimate the independent contribution of sNfL for changes in MRI and Expanded Disability Status Scale (EDSS). Age‐corrected sNfL z ‐scores from a normative database of healthy controls were used for sensitivity analyses.
Results
High sNfL levels at baseline were associated with atrophy measures of the whole brain (standardized beta coefficient βj = −0.352, p < 0.001), white matter ( βj = −0.229, p = 0.007), thalamus ( βj = −0.372, p = 0.004), and putamen ( βj = −1.687, p = 0.012). pwMS with high levels of sNfL at baseline and follow‐up had a greater risk of EDSS worsening ( p = 0.007).
Conclusions
Already single time point elevation of sNfL has a distinct effect on brain volume changes over a short‐term period, and repeated high levels of sNfL indicate accumulating physical disability. Serial assessment of sNfL may provide added value in the clinical management of pwMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Medical University of Graz, Graz, Austria.
- Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
- Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
- Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
- Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
- Division of Neuroradiology, Vascular and Interventional Radiology, Medical University of Graz, Graz, Austria.
ORCID-Profile: Arabella Buchmann, Lukas Pirpamer, Daniela Pinter, Birgit Helmlinger, Alexander Pichler, Aleksandra Maleska Maceski, Pascal Benkert, Gerhard Bachmaier, Stefan Ropele, Markus Reindl, David Leppert, Christian Enzinger, Michael Khalil
Zitieren
APA
Buchmann, A., Pirpamer, L., Pinter, D., Voortman, M., Helmlinger, B., Pichler, A., Maceski, A. M., Benkert, P., Bachmaier, G., Ropele, S., Reindl, M., Leppert, D., Kuhle, J., Enzinger, C., & Khalil, M. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.15742
Vancouver
Buchmann A, Pirpamer L, Pinter D, Voortman M, Helmlinger B, Pichler A, et al. High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology. 2023. doi:10.1111/ene.15742
BibTeX
@article{Buchmann2023,
author = {Buchmann, Arabella and Pirpamer, Lukas and Pinter, Daniela and Voortman, Margarete and Helmlinger, Birgit and Pichler, Alexander and Maceski, Aleksandra Maleska and Benkert, Pascal and Bachmaier, Gerhard and Ropele, Stefan and Reindl, Markus and Leppert, David and Kuhle, Jens and Enzinger, Christian and Khalil, Michael},
title = {High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15742}
}
EUVIMED